News
Merck remains a top Big Pharma name with strong leadership, rising sales, and high margins, despite regulatory fears and ...
Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices ...
Merck revealed promising Phase 3 trial results for WINREVAIR, a new treatment aimed at pulmonary arterial hypertension (PAH). The HYPERION study involved about 320 global participants already ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results